Spain· ES:89504
MARAVIROC TARBIS 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
A medicinal product containing maraviroc, registered in Spain by Tarbis Farma S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- maraviroc
- Manufacturer
- Tarbis Farma S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maraviroc in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMaravirocCamber Pharmaceuticals, Inc.
- CzechiaCELSENTRIViiV Healthcare BV, Amersfoort
- NetherlandsCelsentri 150 mg, filmomhulde tablettenViiV healthcare B.V.
- FinlandCELSENTRIOrifarm Oy
- FranceCELSENTRI 150 mg, comprimé pelliculéVIIV HEALTHCARE UK (ROYAUME-UNI)
- SwedenCELSENTRI 150 mg Filmdragerad tablettViiV Healthcare BV
- IrelandCelsentri 150 mg Film-coated tabletViiV Healthcare BV
- SwitzerlandCelsentri
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Maraviroc
- Germany · Maraviroc, Maraviroc Amarox
- France · Maraviroc, Maraviroc Amarox
- United Kingdom (Northern Ireland) · Maraviroc Amarox Limited, Maraviroc Waymade
- Iceland · Celsentri
- Italy · Maraviroc Waymade
- Liechtenstein · Celsentri
- Netherlands · Maraviroc, Maraviroc Amarox
- Norway · Celsentri
- Portugal · Maraviroc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e995c68e-74dd-4ef8-8c4a-3f7238b5bdb2 GET /v1/drugs/e995c68e-74dd-4ef8-8c4a-3f7238b5bdb2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1713358382000}",
"nregistro": "89504",
"substance": "maraviroc"
}See everything about maraviroc.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.